Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.

Weisler, Richard H

Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD. [electronic resource] - Clinical pharmacology in drug development 02 2018 - 160-167 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

2160-7648

10.1002/cpdd.361 doi


Administration, Oral
Adolescent
Adult
Area Under Curve
Attention Deficit Disorder with Hyperactivity--drug therapy
Biological Availability
Central Nervous System Stimulants--adverse effects
Cross-Over Studies
Delayed-Action Preparations--adverse effects
Dietary Fats--pharmacology
Fasting--metabolism
Female
Food-Drug Interactions
Healthy Volunteers
Humans
Male
Methylphenidate--adverse effects
Tablets
Therapeutic Equivalency
Young Adult